COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.3 | 8 | 0047-0254 | 91.96 | 254.52 | 319 | 73.70 | 0.738 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 341.8 | 8 | 0048-0259 | 345.30 | 258.91 | 262 | 60.77 | 0.892 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 186.6 | 8 | 0049-0267 | 175.50 | 267.03 | 342 | 69.60 | 0.887 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.1 | 8 | 0050-0268 | 413.70 | 268.21 | 323 | 71.50 | 0.794 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 226.6 | 8 | 0051-0269 | 476.36 | 269.60 | 262 | 62.87 | 0.833 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.2 | 8 | 0052-0267 | 608.28 | 266.91 | 333 | 69.01 | 0.879 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 543.7 | 8 | 0053-0276 | 824.72 | 276.05 | 241 | 71.26 | 0.596 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 309.3 | 8 | 0054-0280 | 327.52 | 280.38 | 308 | 69.94 | 0.791 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 226.7 | 8 | 0055-0286 | 908.01 | 285.70 | 313 | 68.53 | 0.838 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.8 | 8 | 0056-0287 | 257.30 | 287.08 | 289 | 64.18 | 0.882 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.7 | 8 | 0057-0296 | 114.24 | 295.98 | 271 | 60.28 | 0.937 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 230.9 | 8 | 0058-0301 | 527.71 | 301.18 | 325 | 70.43 | 0.823 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 305.8 | 8 | 0059-0303 | 773.32 | 302.44 | 372 | 73.26 | 0.871 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 249.5 | 8 | 0060-0301 | 67.03 | 300.89 | 265 | 60.77 | 0.902 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 202.2 | 8 | 0061-0306 | 726.59 | 306.20 | 334 | 67.60 | 0.919 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 221.8 | 8 | 0062-0307 | 454.46 | 307.65 | 280 | 64.77 | 0.839 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 213.3 | 8 | 0063-0312 | 484.66 | 310.84 | 355 | 71.01 | 0.885 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.8 | 8 | 0064-0309 | 802.16 | 310.13 | 312 | 67.01 | 0.873 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 270.1 | 8 | 0065-0309 | 596.25 | 308.86 | 334 | 68.77 | 0.887 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.2 | 8 | 0066-0316 | 693.21 | 316.50 | 327 | 69.94 | 0.840 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 406.1 | 8 | 0067-0314 | 860.26 | 314.34 | 217 | 55.94 | 0.871 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 244.2 | 8 | 0068-0321 | 66.27 | 321.41 | 288 | 64.18 | 0.879 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 208.2 | 8 | 0069-0340 | 518.16 | 340.62 | 344 | 70.18 | 0.878 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 218.9 | 8 | 0070-0341 | 265.73 | 342.16 | 331 | 68.18 | 0.895 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.5 | 8 | 0071-0351 | 434.28 | 351.13 | 305 | 66.53 | 0.866 |